Shuttle Pharmaceuticals Inc Form 4 Submitted on July 15

Published on 7/15/2026

Shuttle Pharmaceuticals Inc Form 4 Submitted on July 15

AI Summary

Summarized by AI from the source below

Shuttle Pharmaceuticals Inc filed a Form 4 with the SEC on July 15. This filing typically includes information about transactions made by company insiders. Such disclosures can provide insight into the trading activities and possible stock price movements of the company. Tracking these filings is important for investors looking to assess insider confidence in Shuttle Pharmaceuticals Inc.

Get the free market brief

Top stories and analysis, summarized. No spam, unsubscribe anytime.